340450 Stock Chart & Stats
₩4745.00
-₩240.00(-4.81%)
―
--
Day’s Range― - ―
52-Week Range₩4,225.00 - ₩9,520.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)132.01K
Market Cap
₩117.90B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)24.6
Beta0.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,650,793
10 Day Avg. Volume110,464
30 Day Avg. Volume132,008
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)₩65.49T
340450 FAQ
What was GC Genome Corp.’s price range in the past 12 months?
GC Genome Corp. lowest stock price was ₩4225.00 and its highest was ₩9520.00 in the past 12 months.
What is GC Genome Corp.’s market cap?
GC Genome Corp.’s market cap is ₩117.90B.
When is GC Genome Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GC Genome Corp.’s earnings last quarter?
GC Genome Corp. released its earnings results on May 15, 2026. The company reported ₩34.404 earnings per share for the quarter, beating the consensus estimate of N/A by ₩34.404.
Is GC Genome Corp. overvalued?
According to Wall Street analysts GC Genome Corp.’s price is currently Undervalued.
Does GC Genome Corp. pay dividends?
GC Genome Corp. does not currently pay dividends.
What is GC Genome Corp.’s EPS estimate?
GC Genome Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GC Genome Corp. have?
GC Genome Corp. has 23,650,793 shares outstanding.
What happened to GC Genome Corp.’s price movement after its last earnings report?
GC Genome Corp. reported an EPS of ₩34.404 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.65%.
Which hedge fund is a major shareholder of GC Genome Corp.?
Currently, no hedge funds are holding shares in KR:340450
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Macrogen, Inc.
―
NanoenTek, Inc.
―
ISU Abxis Co., Ltd.
―
Celemics, Inc.
―
Genohco, Inc.
―